Levetiracetam Tablet, Film Coated
Product Images NDC 50090-6378

12 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-6378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (28bc73b1 951f 459b 83ec 57aae9aafdda 01)

Figure 1 (28bc73b1 951f 459b 83ec 57aae9aafdda 01)
A mathematical formula illustrating the calculation of total daily dose (mL/day) by multiplying the daily dose (mg/kg/day) by patient weight (kg) and dividing the result by 100 mg/mL concentration.*
FDA Label Image

Figure 2 (28bc73b1 951f 459b 83ec 57aae9aafdda 02)

Figure 2 (28bc73b1 951f 459b 83ec 57aae9aafdda 02)
A text panel showing a formula for adjusting creatinine clearance (CLcr) using age, weight, serum creatinine, and a factor for female patients. It also includes an adjustment for body surface area (BSA) to calculate CLcr in mL/min/1.73m² based on the subject's BSA.*
FDA Label Image

Structure (28bc73b1 951f 459b 83ec 57aae9aafdda 03)

Structure (28bc73b1 951f 459b 83ec 57aae9aafdda 03)
Chemical structure diagram of the active ingredient Levetiracetam, showing its molecular framework including a pyrrolidone ring and side chains with functional groups.*
FDA Label Image

Figure 4 (28bc73b1 951f 459b 83ec 57aae9aafdda 04)

Figure 4 (28bc73b1 951f 459b 83ec 57aae9aafdda 04)
Bar chart showing the percentage of patients across three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The y-axis represents the percentage of patients from 0% to 45%.*
FDA Label Image

Figure 5 (28bc73b1 951f 459b 83ec 57aae9aafdda 05)

Figure 5 (28bc73b1 951f 459b 83ec 57aae9aafdda 05)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients, with values shown as 6.3% for Placebo, 20.8% for Levetiracetam 1000 mg/day, and 35.2% for Levetiracetam 2000 mg/day.*
FDA Label Image

Figure 6 (28bc73b1 951f 459b 83ec 57aae9aafdda 06)

Figure 6 (28bc73b1 951f 459b 83ec 57aae9aafdda 06)
A bar chart comparing the percentage of patients between a placebo group and a group taking Levetiracetam 3000 mg/day. The vertical axis represents the percentage of patients, with the placebo group at 14.4% and the Levetiracetam group at 39.4%. Sample sizes are indicated for each group.*
FDA Label Image

Figure 7 (28bc73b1 951f 459b 83ec 57aae9aafdda 07)

Figure 7 (28bc73b1 951f 459b 83ec 57aae9aafdda 07)
A bar chart comparing the percentage of patients between two groups: Placebo (N=97) at 19.6% and Levetiracetam (N=101) at 44.6%. The y-axis represents the percentage of patients ranging from 0% to 45%. An asterisk is shown above the Levetiracetam bar.*
FDA Label Image

Figure 8 (28bc73b1 951f 459b 83ec 57aae9aafdda 08)

Figure 8 (28bc73b1 951f 459b 83ec 57aae9aafdda 08)
A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The y-axis represents the percentage of patients from 0% to 45%. The placebo group (N=51) shows 19.6%, while the Levetiracetam group (N=58) shows 43.1%, with an asterisk indicating statistical significance.*
FDA Label Image

Figure 9 (28bc73b1 951f 459b 83ec 57aae9aafdda 09)

Figure 9 (28bc73b1 951f 459b 83ec 57aae9aafdda 09)
A bar chart comparing the percentage of patients between two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis shows the percentage of patients from 0% to 100%. The chart highlights a higher percentage in the Levetiracetam group.*
FDA Label Image

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 615 1)

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 615 1)
Levetiracetam 1000 mg film-coated tablet packaging from A-S Medication Solutions. The image shows a clear blister pack with four round, pink tablets arranged in a single row with perforations for separating individual doses.*
FDA Label Image

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 638 1)

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 638 1)
Levetiracetam 1000 mg film-coated oral tablet packaging. The visible side shows the tablet arranged in a pattern against a plain background. The labeler is A-S Medication Solutions.*
FDA Label Image

Label Image (Lbl500906378)

Label Image (Lbl500906378)
Levetiracetam 1000 mg film-coated tablets label from A-S Medication Solutions. The label shows the active ingredient Levetiracetam USP 1000 mg per tablet, indicates storage at 77 degrees Fahrenheit, and states the package contains 30 tablets. It includes the product NDC 50090-6378-0 and a QR code with a barcode below.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.